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ABSTRACT 
 
Diabetes  mellitus,  a me tabolic  disorder, is  characterized  by hy perglycemia a nd alt ered 
metabolism. The administration of D-Nil plus (a polyherbal drug) showed effective treatment 
for alloxan induced diabetes in rats. In diabetic rats, h aematological profiles namely RBC, 
WBC, platlet count and  haemoglobin were d ecreased whereas ESR was increased. Similarly 
biochemical parameters creatinine, urea and protein were decreased but cholesterol level was 
increased. After the treatment with D-Nil plus, haematological parameters and biochemical 
parameters were reversed. The results suggest that the D-Nil plus can be used for the treatment 
of diabetes. 
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INTRODUCTION 
 
Diabetes  mellitus, w hich  is  a sy ndrome 
characterized b y  abnormal insulin  
secretion, al tering car bohydrate, protein  
and fat metabolism in addition to damaging 
β cells of pancreas, and liver and kidney
1. 
Hyperglycemia, i mpaired gluc ose 
metabolism and base membrane alterations 
were  mainly ass ociated with   diabetes 
mellitus
2.  It i s  multifaceted  and dyna mic 
expressions  of pat hological dis equilibria, 
which are   closely  related an d  even 
intermingled by  co mmon  factors s uch  as 
obesity, hyperinsulinemia, micro and macro 
vascular disease and cardiac risk factor
3. 
Medicinal p lants  are th e source  of great 
economic val ue in   the  Indian  sub 
continent
4. Herbal m edicine  is  still the  
mainstay o f a bout 75- 80% of  the whole 
population, mainly in d eveloping countries 
for primary health care system because of 
better cultural acce ptability, be tter 
compatibility wi th  the  human b ody a nd 
fewer side effects
5.  Now a da y,  multiple 
drug  resistance has d eveloped du e to th e 
indiscriminate use of  commercial synthetic 
drugs
6.  A  number of p lants have been  
found to be useful in diab etes mellitus and 
compounds  have also been purifie d fro m 
some p lants. The purpose of th is st udy, 
therefore, i s to ex amine  the  antidiabetic 
effect of D-Nil plus using a diabetic animal 
model.                                                                              
 
MATERIALS AND METHODS 
PLANT MATERIAL 
 
The ingred ients of the po lyherbal drug, 
leaves of  Gymnema sylvestre, leav es  of 
Coccinia indica, roots of Salacia reticulata, 
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shilajith  (gummy ma trix), fruit s  of 
Momordica charantia, seeds of Trigonella 
foenum a nd  rhizome  of  Curcuma longum 
were obtained and aut henticated  in th e 
Taxonomy Division,  D epartment  of 
Botany,  Kongunadu  Arts and S cience 
College, Bharathiar University, Coimbatore  
where voucher specimen was deposited. 
 
PREPARATION OF THE HERBAL 
POWDER 
 
The dried p arts  of th e  selected  medicinal 
plants  and shila jith  (75 m g each )  were 
powdered and b lended in a dehu midified 
chamber using mechanical blenders to form 
a uniform blend. 
 
ANIMALS 
 
Wistar strains of male albino rats, weighing 
200-250g obtain ed fro m Thrissu r 
Government Vet erinary Coll ege, Thrissur 
were used for the study. The  animals were 
maintained at  25
0± 3
0C in well  ventilated 
animal hou se  under nat ural photoperio d 
conditions  in large  polypropylene ca ges. 
They were fed with  standard pe llet  diet 
obtained fro m  Hindustan Lev er Lt d., 
Bangalore and water ad libitum. 
 
The animals were divided into four groups 
of six  animals e ach.  Group  I, served as  
control rats, were fed w ith normal diet. In 
Group II, the diabetes was  induced in rats 
by the ad ministration o f freshly  prep ared 
alloxan (60mg / kg  body weight)
 7. Group 
III, alloxan induced animals received D-Nil 
plus powder at a dose of 150mg / kg body 
weight in  dist illed w ater oral ly 
administered twice per day for 15 days. In 
Group IV,  t he no rmal r ats were 
administered with herbal  pow der  for  15 
days. 
 
HAEMATOLOGICAL AND 
BIOCHEMICAL PARAMETERS 
 
Haematological p arameters  namely 
haemoglobin, RBC, WBC,  platlet count  
and ESR w ere carried out b y  routine 
laboratory m ethods.  Biochemical 
parameters na mely p rotein, urea  and 
creatinine w ere assay ed a ccording to the  
methods described by Lowry et al (1951)
 8, 
Varley et al (1976)
 9 and Roswe et al (1953)
 
10 respectively. 
 
STASTICAL ANALYSIS 
 
Data are reported  as  mean  ± SD  and 
statistical analysis for significance was by  
the one  way A NOVA usi ng DMRT 
(Duncan’s Multiple Range Test) with level 
of significance as P< 0.05. 
 
RESULTS AND DISCUSSIONS 
 
             The  result  of  the  haematological 
parameters and biochemical parameters are 
reported in tab le 1 a nd figure 1. Diab etic 
animals (gr oup II)  exhibited signifi cant 
decrease in  WBC , platlet coun t  and RBC 
and significant increase in the level of ESR. 
The h aematological  changes pr oduced 
during diabetic condition were found to b e 
reverted significantly to near normal upon 
administration of the herba l extract     (D-
Nil plus) in alloxan induced rats (group III). 
No significant change in WBC and ESR hr 
was observed in  group  IV rats  whereas  a 
significant  decrease in RBC, platlet count 
and ESR 1 hr was noticed. 
 
The lev els  of u rea and  creatinine  were 
found  to be elevated in allox an induced  
diabetic rats  (group II). A dministration of 
D-Nil plus to alloxan induced rats (group 
III) was found to be s ignificantly reduced 
the  levels of urea  and  creatinine  to near  
normal wh ich  might be due  to  its 
hepatoprotective acti vity.  No  significant 
changes in urea and c reatinine levels were 
observed in group IV  rats when compared 
to group I  control  animals. Ther e  was a 
marked decrease in th e protein contents of 
diabetic gro up  (group  II) w hen com pared 
with control group. Treatm ent with herbal 
preparation w as foun d to  control  this 
metabolic disturbance and was able to bring 
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these levels to near normal (group III). In 
group IV, prote in levels were found  to be 
significantly decreased  when co mpared  to 
the control group. 
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TABLE 1 
 
       UREA AND CREATININE LEVELS IN SERUM OF CONTROL AND 
EXPERIMENTAL RATS 
 
Parameters  Group I 
(Control) 
Group II 
(Alloxan) 
Group III 
(Alloxan + D-Nil 
plus) 
Group IV 
(D-Nil Plus) 
 
Urea (mg/dl) 
 
Creatinine (mg/dl) 
 
Protein (mg/dl) 
 
35.67 ± 1.36 
 
0.83 ± 0.03 
 
6.28   ± 0.44 
 
68.17 ± 4.60
a* 
 
2.12 ± 0.18
a* 
 
3.67   ± 0.39
a* 
 
42.00 ± 4.32
b* 
 
0.95 ± 0.11
b* 
 
5.90   ± 0.21
b* 
 
 
36.88 ± 1.24
cns 
 
0.73 ± 0.04
cns 
 
5.07   ± 0.34
c* 
          Values are mean ± SD from 6 rats in each group 
         * -  p<0.05   ns -  Not significant 
 
       
 
 
 
 
TABLE  2 
   HEMATOLOGICAL PARAMETERS IN CONTROL AND EXPERIMENTAL RATS 
Parameters  Group I 
(Control) 
Group II 
(Alloxan) 
Group III 
(Alloxan + D-Nil 
plus) 
Group IV 
(D-Nil Plus) 
 
WBC  
(Thousand / mm
3) 
 
RBC  
(million/mm
3) 
 
Platlet count 
(Lakhs / ml) 
 
ESR ½ hr 
 
ESR 1 hr 
 
9.13 ± 0.42 
 
 
5.50 ± 0.31 
 
 
3.20 ± 0.33 
 
 
6.70 ± 0.35 
 
12.54 ± 0.30 
 
6.73 ± 0.33
a* 
 
 
3.98 ± 0.28
a* 
 
 
1.95 ± 0.10
a* 
 
 
9.87 ± 0.23
a* 
 
15.27 ± 0.21
a* 
 
8.88 ± 0.60
b* 
 
 
4.95 ± 0.46
b* 
 
 
2.98 ± 0.15
b* 
 
 
6.15 ± 0.33
b* 
 
12.95 ± 0.17
b* 
 
8.40 ± 0.80
cns 
 
 
4.77 ± 0.34
c* 
 
 
2.75 ± 0.17
c* 
 
 
6.57 ± 0.23
cns 
 
12.03 ± 0.21
c* 
      Values are mean ± SD from 6 rats in each group 
 * -  p<0.05   ns -  Not significant 
Statistical comparisons : 
a  -  Group II is compared with Group I 
b  -  Group III is compared with Group II 
c  -  Group IV is compared with Group I 
Statistical comparisons : 
a  -  Group II is compared with Group I 
b  -  Group III is compared with Group II 
c  -  Group IV is compared with Group I 
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